報價延遲最少15分鐘:2025/01/13 09:07 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
-- 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.84/--
|
|
企業價值
235.80M
|
| 資產負債 |
|
每股賬面淨值
23.17
|
| 現金流量 |
|
現金流量率
0.11
|
| 損益表 |
|
收益
37.76M
|
|
每股收益
3.08
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/13 09:07 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment. |